Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2011, Vol. 31 Issue (06): 1-5    DOI:
    
Prokaryotic Expression, Analysis and Identification of Human Polypyrimidine Tract Binding Protein-associated Splicing Factor
WANG Hui-juan1, LAN Yang1, LIU Tao1, LI Ling1,2
1. Functional Genome Laboratory, College of Life Science, Sichuan University, Chengdu 610064, China;
2. Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical School, Haikou 571101, China
Download: HTML   PDF(629KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Polypyrimidine tract binding protein-associated splicing factor (PSF), a multifunctional RNA/DNA-binding protein, can suppress the expression of proto-oncogene and function as tumor suppressor protein (TSP) in human and mouse. Using total RNA extracted from human fibroblasts, PSF-encoding cDNA was synthesized and inserted into vector pET-28a(+) to construct the recombinant plasmid pET-28-PSF. The PSF fused with His-tag was expressed in E.coli BL21 (DE3) by IPTG induction and then purified by affinity chromatography. SDS-PAGE and Western blotting results indicated the soluble His-tagged PSF could be produced with a prokaryotic expression system. Finally, the RNA-binding capacity of recombinant PSF to mVL30-1 RNA was determined by Gel-shift assay. The results indicate that recombinant PSF produced with a prokaryotic expression system can be biologically active and will therefore allow us to investigate the function of PSF in the future.



Key wordsPSF      Tumor      Prokaryotic expression     
Received: 21 February 2011      Published: 28 June 2011
ZTFLH:  Q786  
Corresponding Authors: Li Ling     E-mail: leolibeike@gmail.com
Cite this article:

WANG Hui-juan, LAN Yang, LIU Tao, LI Ling. Prokaryotic Expression, Analysis and Identification of Human Polypyrimidine Tract Binding Protein-associated Splicing Factor. China Biotechnology, 2011, 31(06): 1-5.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2011/V31/I06/1

[1] Sutherland L C, Rintala-Maki N D, White R D, et al. RNA binding motif (RBM) proteins: a novel family of apoptosis modulators? J Cellular Biochemistry, 2005, 94(1): 5-11.
[2] Peng R, Dye B T, Perez I, et al. PSF and p54 nrb bind a conserved stem in U5 snRNA. RNA, 2002, 8(6): 1334-1347.
[3] Mathur M, Tucker P W, Samuels H H. PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. Mol Cell Biol, 2001, 21(10): 2298-2311.
[4] Bladen C L, Udayakumar D, Takeda Y, et al. Identification of the polypyrimidine tract binding protein-associated splicing factor p54(nrb) complex as a candidate DNA double-strand break rejoining factor, J Biol Chem, 2005, 280(10): 5205-5210.
[5] Akhmedov A T, Lopez B S. Human 100-kDa homologous DNA-pairing protein is the splicing factor PSF and promotes DNA strand invasion. Nucleic Acids Res, 2000, 28(11): 3022-3030.
[6] Zolotukhin A S, Michalowski D, Bear J, et al. PSF acts through the human immunodeficiency virus type1 mRNA instability elements to regulate virus expression. Mol Cell Biol, 2003, 23(7): 6618-6630.
[7] Song X, Wang B, Bromberg M E, et al. Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in SCID mice. Proc Natl Acad Sci USA, 2002, 99 (9): 9269-6273.
[8] Song X, Sui A, Garen A. Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: Effects on steroidogenesis and oncogenesis. Proc Natl Acad Sci USA, 2004, 101(2): 621-625.
[9] Song X, Sun Y, Garen A. Role of PSF protein and VL30 RNA in reversible gene regulation. Proc Natl Acad Sci USA, 2005, 102 (34): 12189-12193.
[10] Garen A, Song X. Regulatory roles of tumor-suppressor proteins and noncoding RNAs in cancer and normal cell function. Int J Cancer, 2008, 122(6): 1687-1691.
[11] Galietta A, Gunby R H, Redaelli S, et al. NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma. Blood, 2007, 110(7): 2600-2609.

[1] ZHAO Meng-ze,LI Feng-zhi,WANG Peng-yin,LI Jian,XU Han-mei. Research Progress of Dual-target Blocking Therapy of PD-L1 and VEGF[J]. China Biotechnology, 2021, 41(9): 71-77.
[2] QIAO Sheng-tai,WANG Man-qi,XU Hui-ni. Functional Analysis of Prokaryotic Expression Protein of Tomato SlTpx in Vitro[J]. China Biotechnology, 2021, 41(8): 25-32.
[3] LV Hui-zhong,ZHAO Chen-chen,ZHU Lian,XU Na. Progress of Using Exosome for Drug Targeted Delivery in Tumor Therapy[J]. China Biotechnology, 2021, 41(5): 79-86.
[4] ZHANG Lei,TANG Yong-kai,LI Hong-xia,LI Jian-lin,XU Yu-xin,LI Ying-bin,YU Ju-hua. Advances in Promoting Solubility of Prokaryotic Expressed Proteins[J]. China Biotechnology, 2021, 41(2/3): 138-149.
[5] YUAN Bo,WANG Jie-wen,KANG Guang-bo,HUANG He. Research Progress and Application of Bispecific Nanobody[J]. China Biotechnology, 2021, 41(2/3): 78-88.
[6] DENG Rui,ZENG Jia-li,LU Xue-mei. Screening and Structure-activity Relationship Analysis of Anti-tumor Derived Peptides Based on Musca domestica cecropin[J]. China Biotechnology, 2021, 41(11): 14-22.
[7] ZHANG Xiao-hang,LI Yuan-yuan,JIA Min-xuan,GU Qi. Identification and Expression of Elastin-like Polypeptides[J]. China Biotechnology, 2020, 40(8): 33-40.
[8] LV Yi-fan,LI Geng-dong,XUE Nan,LV Guo-liang,SHI Shao-hui,WANG Chun-sheng. Prokaryotic Expression, Purification of LbCpf1 Protein Gene and in Vitro Cleavage Activity Assay[J]. China Biotechnology, 2020, 40(8): 41-48.
[9] LIN Shi-xin,LIU Dong-chen,LEI Yun,XIONG Sheng,XIE Qiu-ling. Screening, Expression and Specificity Detection of Anti-TNF-α Nanobody[J]. China Biotechnology, 2020, 40(7): 15-21.
[10] YANG Wei,SONG Fang-xiang,WANG Shuai,ZHANG Li,WANG Hong-xia,LI Yan. Preparation and Application of Janus Nanoparticles in Drug Delivery System[J]. China Biotechnology, 2020, 40(7): 70-81.
[11] ZHANG Bao-hui,XIONG Hua-long,ZHANG Tian-ying,YUAN Quan. Research Progress on Vesicular Stomatitis Virus-based Oncolytic Virotherapy[J]. China Biotechnology, 2020, 40(6): 53-62.
[12] TONG Mei,CHENG Yong-qing,LIU Jin-yi,XU Chen. Construction of a Strain for Promoting Production of Small Molecule Antibodies in Periplasmic Space of Escherichia coli[J]. China Biotechnology, 2020, 40(5): 48-56.
[13] DAI Qi-nan,ZHANG Jing-hong. Advances in Molecular Mechanisms Related to Tumor Multi-drug Resistance, Autophagy, DNA Repair and Tumor Stem Cells[J]. China Biotechnology, 2020, 40(4): 69-77.
[14] LI Tong-tong,SONG Cai-ling,YANG Kai-yue,WANG Wen-jing,CHEN Hui-yu,LIU Ming. Preparation and Neutralization Activity of Anti-Canine Parvovirus VP2 Protein Single-chain Antibody[J]. China Biotechnology, 2020, 40(4): 10-16.
[15] QIAN Ying,QIAN Chen,BAI Xiao-qing,WANG Jing-jing. Application of Adjuvant in Cancer Immunotherapy[J]. China Biotechnology, 2020, 40(3): 96-103.